| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $727.98M | $729.08M | $762.22M | $725.75M | $602.71M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $699.54M | $729.87M | $749.04M | $717.80M | $617.73M |
| R&D | – | – | – | – | – |
| SG&A | $219.54M | $228.87M | $242.70M | $231.81M | $188.28M |
| Operating Income | $28.43M | -$795.00K | $13.18M | $7.94M | -$15.03M |
| Interest Expense | – | – | $42.69M | $20.42M | $9.61M |
| Tax Expense | -$4.23M | -$19.11M | -$8.79M | -$473.00K | -$1.88M |
| Net Income | -$14.91M | -$31.85M | -$18.75M | -$7.58M | -$20.81M |
| EPS (basic) | -1.3800 | -2.1000 | -1.2500 | -0.6700 | -1.5200 |
| EPS (diluted) | -1.3800 | -2.1000 | -1.2500 | -0.6700 | -1.5200 |
| Shares (diluted) | $15.22M | $15.23M | $15.60M | $15.75M | $15.87M |